Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
SELLAS Life Sciences Group, Inc. (SLS) had Weighted-Average Shares Outstanding (Diluted) of 189.18M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-9.61M |
|
-- |
|
-- |
|
$10.63M |
|
$-10.63M |
|
$1.02M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-10.63M |
|
$-10.63M |
|
189.18M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
189.18M |
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$142.50M |
|
-- |
|
$2.88M |
|
$145.38M |
|
$7.57M |
|
-- |
|
$0.16M |
|
$7.73M |
|
$137.66M |
|
$135.74M |
|
$137.66M |
|
201.92M |
|
| Cash Flow Statement Financials | |
$-16.43M |
|
-- |
|
$82.98M |
|
$71.89M |
|
$138.44M |
|
$66.55M |
|
$1.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.98% |
|
-7.08% |
|
-6.61% |
|
-6.98% |
|
$0.68 |
|
$-0.09 |
|
$-0.09 |
|